About Sam Chun Dang Pharma
Sam Chun Dang Pharma is a publicly listed company based in Seoul (South Korea) founded in 1943. Manufacturer of finished pharmaceutical products. The company has 417 employees. Its website scd.co.kr draws about 17 thousand monthly visits. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.
Company details
Sam Chun Dang Pharma was founded in 1943 in Seoul, South Korea, and operates within the pharmaceutical sector. Finished pharmaceutical products are produced using advanced GMP facilities. Research and development efforts are prioritized to introduce new medications. International markets are accessed through product exports. Operations center on consistent production and innovation in drug development.
- Annual Revenue$160.51 M (USD)9.9as on Dec 31, 2025
- Net Profit$3.64 M (USD)as on Dec 31, 2025
- EBITDA$13.38 M (USD)-25.63as on Dec 31, 2025
- Employee Count417
IPO & Listings of Sam Chun Dang Pharma
Sam Chun Dang Pharma is a publicly listed company on the KRX with ticker symbol 000250 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date04 Oct 2000
- Listed onKRX: 250
- Listed entitySam Chun Dang Pharm. Co., Ltd.
- Exchange sectorHealth technology
- ISINKR7000250001
- Share price206,000.00 KRW (-2.14% on the day) · 2026-10-14
- Market capitalisation4,895,698,064,804.00 KRW
- Price to earnings270.2
- EPS (diluted, trailing year)762.29 KRW
- Dividend yield0.02%
- Volume (last session)97,254
Financials of Sam Chun Dang Pharma
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 231.81B KRW | 5.26B KRW | 19.32B KRW |
| 2024 | 210.92B KRW | -10.92B KRW | 25.98B KRW |
| 2023 | 192.67B KRW | -10.38B KRW | 18.08B KRW |
| 2022 | 177.34B KRW | 5.84B KRW | 20.22B KRW |
| 2021 | 167.27B KRW | -16.56B KRW | -8.55B KRW |
Detailed financial statements for Sam Chun Dang Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Sam Chun Dang Pharma
The website of Sam Chun Dang Pharma (scd.co.kr) receives about 16.7K visits a month.
- Monthly visits16.7K
▼ 9.7% vs previous month
Websites whose visitors overlap most with Sam Chun Dang Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
medipana.com | medipana.com | 100% | #266,587 | – | |
medicaltimes.com | medicaltimes.com | 87% | #99,676 | – | |
| medigatenews.com | 86% | #143,063 | View details | ||
samik.co.kr | samik.co.kr | 85% | #2,496,342 | – | |
doctorsnews.co.kr | doctorsnews.co.kr | 85% | #144,717 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 17 similar websites and full traffic analytics for Sam Chun Dang Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 17 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sam Chun Dang Pharma
Complete news archive for Sam Chun Dang Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sam Chun Dang Pharma
Sam Chun Dang Pharma was founded in 1943.
Sam Chun Dang Pharma is headquartered in Seoul, South Korea.
Sam Chun Dang Pharma has 417 employees.
Annual revenue of Sam Chun Dang Pharma is $160.51M as on Dec 31, 2025.
Sam Chun Dang Pharma was founded in 1943 in Seoul, South Korea, and operates within the pharmaceutical sector. Finished pharmaceutical products are produced using advanced GMP facilities. Research and development efforts are prioritized to introduce new medications. International markets are accessed through product exports. Operations center on consistent production and innovation in drug development.
Yes, Sam Chun Dang Pharma is publicly traded on KRX under the ticker symbol 000250.